The Board of Overseers is an advisory body committed to providing counsel and support to the ADDF Board of Governors and staff. Overseers lend their expertise to advance the ADDF's mission to accelerate the discovery of drugs to prevent, treat and cure Alzheimer’s disease. Overseers are appointed by and serve at the pleasure of the Board of Governors.
CO-CHAIRMEN
Sharon T. Sager, CIMA
Managing Director and Private Wealth Advisor, UBS Private Wealth Management
Carol Seabrook Boulanger
Partner, Pillsbury, Winthrop, Shaw, and Pittman, LLP
Charles Cangro
Principal, Personal Financial Services, Ernst & Young
Mitchell D. Eichen, J.D., LL.M.
Founder and Chief Executive Officer, Acertus Capital Management
Founder and Chief Executive Officer, The MDE Group
Allan M. Green, MD, PhD, JD
Allan M. Green Esq., LLC
Christopher Johnson
President and Managing Officer, Rackson Corporation
Bonnie Englebardt Lautenberg
Photographer, Writer
Elise Gelman Lefkowitz
Philanthropist
Philip Lovett
Founding Partner, Millennium Partners
Emilio Matt
Business Development Director, Microsoft Corporation
Julie Medler
Managing Director, Golden Seeds
Pamela J. Newman, Ph.D.
President and Chief Executive Officer, The Newman Team, Aon Corporation
Phebe Farrow Port
Senior Vice President, Global Management Strategies and Chief of Staff, Executive Management Initiatives, The Estée Lauder Companies Inc.
John H. Scully, CIMA
Senior Managing Director, Head of Private Wealth Advisory, Nuveen Investments
Stephen Toma
Managing Director, VJMS, LLC
Wendy L. Wilshin
Founder and Principal, WLW Designs
Alison Zaino
Philanthropist
Linda S. Zambelli
Managing Director, U.S. Trust, Bank of America Private Wealth Management